secwatch.observer — SEC 8-K summary
======================================

Issuer:     Third Harmonic Bio, Inc. (—)
CIK:        0001923840
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001193125-25-089270
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Third Harmonic Bio CSO Christopher Dinsmore steps down effective April 21, 2025
-------------------------------------------------------------------------------

- Christopher Dinsmore resigned as Chief Scientific Officer on April 21, 2025.
- He will receive a lump-sum severance of 9 months' salary and healthcare cost coverage for up to 9 months.
- Separation agreement includes release of claims, non-disparagement, and confidentiality provisions.
- No successor has been announced; Dinsmore's departure leaves the CSO role vacant.
- Severance benefits are contingent on compliance with the separation agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1923840/000119312525089270/0001193125-25-089270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1923840/000119312525089270/d829877d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-089270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer